Global Clinical Communication & Collaboration Market

Clinical Communication & Collaboration Comprehensive Study by End Use (Hospitals, Clinics, Others), Deployment (On Cloud, On Premise), Organisation Size (SMEs, Large Organisations), Component (Solution, Services) Players and Region - Global Market Outlook to 2026

Clinical Communication & Collaboration Market by XX Submarkets | Forecast Years 2020-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Clinical Communication & Collaboration?
Clinical Communication & Collaboration is a healthcare technology which enables healthcare professionals such as physicians, nurses and other staff to securely communicate and integrate their clinical systems for enhanced synergy, cooperation and efficiency of the entire healthcare system in the hospital or clinic. The CC&C systems enables to exchange data on coordinate activities. It also comprises of medical staff scheduling software, EHRs, healthcare messaging software, among other healthcare management related software. The CC&C services can be largely beneficial for operations of hospitals, clinics, ancillary care providers, and laboratories. Currently, North America accounts for largest market share.

The market study is broken down and major geographies with country level break-up.

Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Vocera Communications (United States), Microsoft Corporation (United States), Agnity Inc. (United States), Cisco Systems Inc. (United States), TigerConnect, Inc. (United States), Uniphy Health Systems LLC (United States), PerfectServe, Inc. (United States), Jive Software (United States), UDG Healthcare PLC (Ireland) and Cerner Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Spok Inc. (United States), Ascom Holding AG (Switzerland) and Voalte (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Clinical Communication & Collaboration market by Type, Application and Region.

On the basis of geography, the market of Clinical Communication & Collaboration has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Clinical Communication & Collaboration market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Deployment, the sub-segment i.e. On Cloud will boost the Clinical Communication & Collaboration market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Organisation Size , the sub-segment i.e. SMEs will boost the Clinical Communication & Collaboration market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Component, the sub-segment i.e. Solution will boost the Clinical Communication & Collaboration market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2021, Vocera Communications, Inc., a United States based leading workflow optimization and communication platform provider specifically designed for healthcare industry has announced acquisition of PatientSafe Solutions, which provides single mobile based application for clinical communication, EMRs, and mission critical workflow management. The acquisition deal will expand the market base of Vocera to small and medium sized hospitals as well as clinics, whereas PatientSafe can benefit from the expertise of the Vocera in deploying cloud ready solutions.
In 2019, PerfectServe, Inc., a cloud-based clinical communication and collaboration solutions provider has announced acquisition of Lightning Bolt Solutions, a physician shift-scheduling platform for hospitals and health systems, and CareWire, a mobile patient engagement platform. The acquisition will enable PerfectServe to provide end to end comprehensive solutions under CC&C market. The AI based technology of Lightning Bolt will also consolidate PerfectServe’s artificial intelligence capabilities.


Market Trend
  • Artificial Intelligence (AI)-led Telemedicine Services are rising in Popularity and have the Potential to Revolutionize Clinical Communication Market

Market Drivers
  • Recent Pandemic has resulted in Increasing Need for Coordination and Communication in Healthcare
  • Advancements in Communication and Healthcare Technology
  • Rising Investments in the Healthcare Industry

Opportunities
  • Secure Mobile Based Communication Solutions between Healthcare Professionals and Patients is expected to Drive Future Growth in Market

Restraints
  • Lack of IT and Telecom Infrastructure in Developing Countries

Challenges
  • Risk of Data Breach of Confidential Medical Information


Key Target Audience
Clinical Communication & Collaboration Developers and Providers, New Entrants/Investors, Venture Capitalists and Private Equity Firms and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By End Use
  • Hospitals
  • Clinics
  • Others

By Deployment
  • On Cloud
  • On Premise

By Organisation Size
  • SMEs
  • Large Organisations

By Component
  • Solution
  • Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Recent Pandemic has resulted in Increasing Need for Coordination and Communication in Healthcare
      • 3.2.2. Advancements in Communication and Healthcare Technology
      • 3.2.3. Rising Investments in the Healthcare Industry
    • 3.3. Market Challenges
      • 3.3.1. Risk of Data Breach of Confidential Medical Information
    • 3.4. Market Trends
      • 3.4.1. Artificial Intelligence (AI)-led Telemedicine Services are rising in Popularity and have the Potential to Revolutionize Clinical Communication Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Communication & Collaboration, by End Use, Deployment, Organisation Size , Component and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Clinical Communication & Collaboration (Value)
      • 5.2.1. Global Clinical Communication & Collaboration by: End Use (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Clinics
        • 5.2.1.3. Others
      • 5.2.2. Global Clinical Communication & Collaboration by: Deployment (Value)
        • 5.2.2.1. On Cloud
        • 5.2.2.2. On Premise
      • 5.2.3. Global Clinical Communication & Collaboration by: Component (Value)
        • 5.2.3.1. Solution
        • 5.2.3.2. Services
      • 5.2.4. Global Clinical Communication & Collaboration Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Clinical Communication & Collaboration: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Vocera Communications (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Microsoft Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agnity Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cisco Systems Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. TigerConnect, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Uniphy Health Systems LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PerfectServe, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Jive Software (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. UDG Healthcare PLC (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cerner Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Communication & Collaboration Sale, by End Use, Deployment, Organisation Size , Component and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Clinical Communication & Collaboration (Value)
      • 7.2.1. Global Clinical Communication & Collaboration by: End Use (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Clinics
        • 7.2.1.3. Others
      • 7.2.2. Global Clinical Communication & Collaboration by: Deployment (Value)
        • 7.2.2.1. On Cloud
        • 7.2.2.2. On Premise
      • 7.2.3. Global Clinical Communication & Collaboration by: Component (Value)
        • 7.2.3.1. Solution
        • 7.2.3.2. Services
      • 7.2.4. Global Clinical Communication & Collaboration Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Communication & Collaboration: by End Use(USD Million)
  • Table 2. Clinical Communication & Collaboration Hospitals , by Region USD Million (2014-2019)
  • Table 3. Clinical Communication & Collaboration Clinics , by Region USD Million (2014-2019)
  • Table 4. Clinical Communication & Collaboration Others , by Region USD Million (2014-2019)
  • Table 5. Clinical Communication & Collaboration: by Deployment(USD Million)
  • Table 6. Clinical Communication & Collaboration On Cloud , by Region USD Million (2014-2019)
  • Table 7. Clinical Communication & Collaboration On Premise , by Region USD Million (2014-2019)
  • Table 8. Clinical Communication & Collaboration: by Component(USD Million)
  • Table 9. Clinical Communication & Collaboration Solution , by Region USD Million (2014-2019)
  • Table 10. Clinical Communication & Collaboration Services , by Region USD Million (2014-2019)
  • Table 11. South America Clinical Communication & Collaboration, by Country USD Million (2014-2019)
  • Table 12. South America Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 13. South America Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 14. South America Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 15. South America Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 16. Brazil Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 17. Brazil Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 18. Brazil Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 19. Brazil Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 20. Argentina Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 21. Argentina Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 22. Argentina Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 23. Argentina Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 24. Rest of South America Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 25. Rest of South America Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 26. Rest of South America Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 27. Rest of South America Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 28. Asia Pacific Clinical Communication & Collaboration, by Country USD Million (2014-2019)
  • Table 29. Asia Pacific Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 30. Asia Pacific Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 31. Asia Pacific Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 32. Asia Pacific Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 33. China Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 34. China Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 35. China Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 36. China Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 37. Japan Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 38. Japan Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 39. Japan Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 40. Japan Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 41. India Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 42. India Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 43. India Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 44. India Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 45. South Korea Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 46. South Korea Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 47. South Korea Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 48. South Korea Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 49. Taiwan Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 50. Taiwan Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 51. Taiwan Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 52. Taiwan Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 53. Australia Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 54. Australia Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 55. Australia Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 56. Australia Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 57. Rest of Asia-Pacific Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 58. Rest of Asia-Pacific Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 59. Rest of Asia-Pacific Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 60. Rest of Asia-Pacific Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 61. Europe Clinical Communication & Collaboration, by Country USD Million (2014-2019)
  • Table 62. Europe Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 63. Europe Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 64. Europe Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 65. Europe Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 66. Germany Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 67. Germany Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 68. Germany Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 69. Germany Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 70. France Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 71. France Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 72. France Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 73. France Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 74. Italy Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 75. Italy Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 76. Italy Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 77. Italy Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 78. United Kingdom Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 79. United Kingdom Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 80. United Kingdom Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 81. United Kingdom Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 82. Netherlands Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 83. Netherlands Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 84. Netherlands Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 85. Netherlands Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 86. Rest of Europe Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 87. Rest of Europe Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 88. Rest of Europe Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 89. Rest of Europe Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 90. MEA Clinical Communication & Collaboration, by Country USD Million (2014-2019)
  • Table 91. MEA Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 92. MEA Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 93. MEA Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 94. MEA Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 95. Middle East Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 96. Middle East Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 97. Middle East Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 98. Middle East Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 99. Africa Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 100. Africa Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 101. Africa Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 102. Africa Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 103. North America Clinical Communication & Collaboration, by Country USD Million (2014-2019)
  • Table 104. North America Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 105. North America Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 106. North America Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 107. North America Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 108. United States Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 109. United States Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 110. United States Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 111. United States Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 112. Canada Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 113. Canada Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 114. Canada Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 115. Canada Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 116. Mexico Clinical Communication & Collaboration, by End Use USD Million (2014-2019)
  • Table 117. Mexico Clinical Communication & Collaboration, by Deployment USD Million (2014-2019)
  • Table 118. Mexico Clinical Communication & Collaboration, by Organisation Size USD Million (2014-2019)
  • Table 119. Mexico Clinical Communication & Collaboration, by Component USD Million (2014-2019)
  • Table 120. Company Basic Information, Sales Area and Its Competitors
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Clinical Communication & Collaboration: by End Use(USD Million)
  • Table 131. Clinical Communication & Collaboration Hospitals , by Region USD Million (2021-2026)
  • Table 132. Clinical Communication & Collaboration Clinics , by Region USD Million (2021-2026)
  • Table 133. Clinical Communication & Collaboration Others , by Region USD Million (2021-2026)
  • Table 134. Clinical Communication & Collaboration: by Deployment(USD Million)
  • Table 135. Clinical Communication & Collaboration On Cloud , by Region USD Million (2021-2026)
  • Table 136. Clinical Communication & Collaboration On Premise , by Region USD Million (2021-2026)
  • Table 137. Clinical Communication & Collaboration: by Component(USD Million)
  • Table 138. Clinical Communication & Collaboration Solution , by Region USD Million (2021-2026)
  • Table 139. Clinical Communication & Collaboration Services , by Region USD Million (2021-2026)
  • Table 140. South America Clinical Communication & Collaboration, by Country USD Million (2021-2026)
  • Table 141. South America Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 142. South America Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 143. South America Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 144. South America Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 145. Brazil Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 146. Brazil Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 147. Brazil Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 148. Brazil Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 149. Argentina Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 150. Argentina Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 151. Argentina Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 152. Argentina Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 153. Rest of South America Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 154. Rest of South America Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 155. Rest of South America Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 156. Rest of South America Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 157. Asia Pacific Clinical Communication & Collaboration, by Country USD Million (2021-2026)
  • Table 158. Asia Pacific Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 159. Asia Pacific Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 160. Asia Pacific Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 161. Asia Pacific Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 162. China Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 163. China Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 164. China Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 165. China Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 166. Japan Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 167. Japan Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 168. Japan Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 169. Japan Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 170. India Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 171. India Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 172. India Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 173. India Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 174. South Korea Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 175. South Korea Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 176. South Korea Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 177. South Korea Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 178. Taiwan Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 179. Taiwan Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 180. Taiwan Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 181. Taiwan Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 182. Australia Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 183. Australia Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 184. Australia Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 185. Australia Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 186. Rest of Asia-Pacific Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 187. Rest of Asia-Pacific Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 188. Rest of Asia-Pacific Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 189. Rest of Asia-Pacific Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 190. Europe Clinical Communication & Collaboration, by Country USD Million (2021-2026)
  • Table 191. Europe Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 192. Europe Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 193. Europe Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 194. Europe Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 195. Germany Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 196. Germany Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 197. Germany Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 198. Germany Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 199. France Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 200. France Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 201. France Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 202. France Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 203. Italy Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 204. Italy Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 205. Italy Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 206. Italy Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 207. United Kingdom Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 208. United Kingdom Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 209. United Kingdom Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 210. United Kingdom Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 211. Netherlands Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 212. Netherlands Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 213. Netherlands Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 214. Netherlands Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 215. Rest of Europe Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 216. Rest of Europe Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 217. Rest of Europe Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 218. Rest of Europe Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 219. MEA Clinical Communication & Collaboration, by Country USD Million (2021-2026)
  • Table 220. MEA Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 221. MEA Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 222. MEA Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 223. MEA Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 224. Middle East Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 225. Middle East Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 226. Middle East Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 227. Middle East Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 228. Africa Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 229. Africa Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 230. Africa Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 231. Africa Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 232. North America Clinical Communication & Collaboration, by Country USD Million (2021-2026)
  • Table 233. North America Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 234. North America Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 235. North America Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 236. North America Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 237. United States Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 238. United States Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 239. United States Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 240. United States Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 241. Canada Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 242. Canada Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 243. Canada Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 244. Canada Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 245. Mexico Clinical Communication & Collaboration, by End Use USD Million (2021-2026)
  • Table 246. Mexico Clinical Communication & Collaboration, by Deployment USD Million (2021-2026)
  • Table 247. Mexico Clinical Communication & Collaboration, by Organisation Size USD Million (2021-2026)
  • Table 248. Mexico Clinical Communication & Collaboration, by Component USD Million (2021-2026)
  • Table 249. Research Programs/Design for This Report
  • Table 250. Key Data Information from Secondary Sources
  • Table 251. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Communication & Collaboration: by End Use USD Million (2014-2019)
  • Figure 5. Global Clinical Communication & Collaboration: by Deployment USD Million (2014-2019)
  • Figure 6. Global Clinical Communication & Collaboration: by Component USD Million (2014-2019)
  • Figure 7. South America Clinical Communication & Collaboration Share (%), by Country
  • Figure 8. Asia Pacific Clinical Communication & Collaboration Share (%), by Country
  • Figure 9. Europe Clinical Communication & Collaboration Share (%), by Country
  • Figure 10. MEA Clinical Communication & Collaboration Share (%), by Country
  • Figure 11. North America Clinical Communication & Collaboration Share (%), by Country
  • Figure 12. Global Clinical Communication & Collaboration share by Players 2019 (%)
  • Figure 13. Global Clinical Communication & Collaboration share by Players (Top 3) 2019(%)
  • Figure 14. Global Clinical Communication & Collaboration share by Players (Top 5) 2019(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Vocera Communications (United States) Revenue, Net Income and Gross profit
  • Figure 17. Vocera Communications (United States) Revenue: by Geography 2019
  • Figure 18. Microsoft Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Microsoft Corporation (United States) Revenue: by Geography 2019
  • Figure 20. Agnity Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Agnity Inc. (United States) Revenue: by Geography 2019
  • Figure 22. Cisco Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cisco Systems Inc. (United States) Revenue: by Geography 2019
  • Figure 24. TigerConnect, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. TigerConnect, Inc. (United States) Revenue: by Geography 2019
  • Figure 26. Uniphy Health Systems LLC (United States) Revenue, Net Income and Gross profit
  • Figure 27. Uniphy Health Systems LLC (United States) Revenue: by Geography 2019
  • Figure 28. PerfectServe, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. PerfectServe, Inc. (United States) Revenue: by Geography 2019
  • Figure 30. Jive Software (United States) Revenue, Net Income and Gross profit
  • Figure 31. Jive Software (United States) Revenue: by Geography 2019
  • Figure 32. UDG Healthcare PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 33. UDG Healthcare PLC (Ireland) Revenue: by Geography 2019
  • Figure 34. Cerner Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Cerner Corporation (United States) Revenue: by Geography 2019
  • Figure 36. Global Clinical Communication & Collaboration: by End Use USD Million (2021-2026)
  • Figure 37. Global Clinical Communication & Collaboration: by Deployment USD Million (2021-2026)
  • Figure 38. Global Clinical Communication & Collaboration: by Component USD Million (2021-2026)
  • Figure 39. South America Clinical Communication & Collaboration Share (%), by Country
  • Figure 40. Asia Pacific Clinical Communication & Collaboration Share (%), by Country
  • Figure 41. Europe Clinical Communication & Collaboration Share (%), by Country
  • Figure 42. MEA Clinical Communication & Collaboration Share (%), by Country
  • Figure 43. North America Clinical Communication & Collaboration Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Vocera Communications (United States)
  • Microsoft Corporation (United States)
  • Agnity Inc. (United States)
  • Cisco Systems Inc. (United States)
  • TigerConnect, Inc. (United States)
  • Uniphy Health Systems LLC (United States)
  • PerfectServe, Inc. (United States)
  • Jive Software (United States)
  • UDG Healthcare PLC (Ireland)
  • Cerner Corporation (United States)
Additional players considered in the study are as follows:
Spok Inc. (United States) , Ascom Holding AG (Switzerland) , Voalte (United States) ,
Select User Access Type

Key Highlights of Report


Aug 2021 222 Pages 72 Tables Base Year: 2019 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Clinical Communication & Collaboration Market Quantitative research analysis
Global Clinical Communication & Collaboration Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Vocera Communications (United States), Microsoft Corporation (United States), Agnity Inc. (United States), Cisco Systems Inc. (United States), TigerConnect, Inc. (United States), Uniphy Health Systems LLC (United States), PerfectServe, Inc. (United States), Jive Software (United States), UDG Healthcare PLC (Ireland) and Cerner Corporation (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Clinical Communication & Collaboration Market to reach USD Million by 2026.

Know More About Global Clinical Communication & Collaboration Market Report?

Have a Query? Click Here

Other Related Reports

Quantum Key Distribution Comprehensive Study by Type (Discrete Variable QKD (DV-QKD), Continuous Variable QKD (CV-QKD)), Industry Vertical (BFSI, Healthcare, Automotive, IT & Telecommunication, Energ...
$ 3750
Navigation System Comprehensive Study by Type (Automotive Navigation System, Global Positioning System (GPS), Marine Navigation System, Surgical Navigation System, Inertial Navigation System, Robotic...
$ 3750
Biometric Authentication & Identification Comprehensive Study by Type (Hardware (Sensors, IP Cameras, Biometric Cards), Software and Service), Application (Access Control, Border Management, Workforc...
$ 3750
Bluetooth LED Bulbs Comprehensive Study by Type (Compact Fluorescent Light (CFL), High-Intensity Discharge Lamps (HID), Fluorescent Lamps (FL), Light Emitting Diodes (LED)), Application (Industrial, ...
$ 3350
Electronic Passports Comprehensive Study by Application (Leisure Travel, Business Travel), End Users (Public, Private), Technology (Radio Frequency Identification, Biometric, Hybrid) Players and Regi...
$ 3500
Video Recorders Comprehensive Study by Type (Digital Recorder, Cloud Recorder, Others), Application (Studio Camera, Field Camera, Sting Camera, Drone Camera, DSLR Camera, Spider Camera, Mobile Camera...
$ 3450